Pyridam Farma Tbk vs Mandom Indonesia Tbk. — how do they compare? Pyridam Farma Tbk trades at Rp214 (market cap 2.31T, 10.47M 24h volume), while Mandom Indonesia Tbk. trades at Rp2,740 (market cap 1.11T, 13.3K 24h volume). The key difference: Pyridam Farma Tbk is far larger — about 2.1× Mandom Indonesia Tbk.'s market cap, and Pyridam Farma Tbk is more actively traded (10.47M versus 13.3K). Which is the better fit depends on your goals.
| PYFA | TCID | |
|---|---|---|
Market Cap | 2.31T | 1.11T |
Volume | 10.47M | 13.3K |
Lot | 104.73K | 133 |
Turnover | 2.2B | 36.73M |
Average Price | 209.71 | 2,761.8 |
Value | 2.2B | 36.73M |
Indicative Equilibrium Price | 214 | — |
Indicative Equilibrium Volume | 10.89K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Pyridam Farma Tbk. Founded in Jakarta based on Limited Company Act on November 27th 1976 and start the commercial operation since 1978 which conduct in pharmaceutical business.On its first establishmnent, the corporate produce & distribute medicine products for livestock & pet.. Since 1985 the corporate develop pharmacy division which emphasize produce and distribute health product for human and for livestock held by veterinary division.
Read more on PYFA →PT. Mandom Indonesia Tbk (the Company), formely PT Tancho Indonesia Tbk was incorporated under the framework of the Foreign Capital Investment law dated November 5, 1969.The Company’s Articles of Association have been amended several times, including change of par value from Rp. 1000 to Rp. 500,- and change in name to PT Tancho Indonesia Tbk. Then increase in the authorized share capital to Rp 312 billion and issued and paid up capital to Rp. 78 billion. At an Extraordinary General Meeting of Share Holders dated November 2000, it was resolved to change the company’s name to PT Mandom Indonesia Tbk.The company is located in Jakarta and factories are located in Jakarta and Industrial Estate MM2100, Cibitung, West Java. The Company commenced commercial production in April 16, 1971.
Read more on TCID →